載入...
Renal fibrosis: not just PAI-1 in the sky
A delicate balance exists between ECM synthesis and degradation such that interruption of the corresponding pathways results in increased plasminogen activator inhibitor-1 (PAI-1), pathological matrix accumulation, and glomerulosclerosis. A new study demonstrates that therapy with a mutant PAI-1 inc...
Na minha lista:
| 主要作者: | |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society for Clinical Investigation
2003
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC166301/ https://ncbi.nlm.nih.gov/pubmed/12897200 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI200319375 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|